Sage Journals: Discover world-class research

Abstract

Intensive care of patients with SAH is targeted to recognize and treat the leading cause of death and disability.

Hemorrhage, vasospasm, rebleeding, intracranial hypertension can produce ischaemia because the ratio between metabolism (CMRO₂) and cerebral blood flow (CBF) is not coupled.

Neuro-ICU bedside monitoring provides information on the intracranial dynamics. Aggressive treatment attempts to avoid ischaemia but needs a clipped or thrombosed (via endovascular approach) aneurysm.

The authors propose treatment to improve CBF and reduce CMRO₂: hypervolemia, hemodilution, hypertension, ICP reduction, normocapnia, mannitol infusion, normothermia or mild hypothermia and sedation with intravenous anaesthetics.

Medical complications such as hypovolemia, infections, pulmonary oedema, gastrointestinal bleeding need to be recognized early and treated.

Get full access to this article

View all access options for this article.

References

Bailes

Spetzler

: Management morbidity and mortality of poor grade aneurysm patients. J Neurosurg 72: 559–566, 1990.

Cold

: Does acute hyperventilation provoke cerebral oligaemia in comatose patients after acute head injury? Acta Neurochihir (Wien) 96: 100–106, 1989.

Cruz

Miner

: Continuous monitoring of cerebral oxygenationinacute brain injury: Assessment of cerebral hemodynamic reserve. Neurosurgery 29: 743–749, 1991.

Guglielmi

Vinuela

: Electrothrombosis of saccular aneurysms via endovascular approach. J Neurosurg 75: 8–14, 1991.

Hase

Reulen

: Intracranial pressure and pressure volume relation in patients with subaracnoid hemorrage. Acta Neurochir 44: 69–80, 1978.

Hunt

Hess

: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28: 14–20, 1968.

Ishii

: Regional cerebral blood flow in patients with a ruptured intracranial aneurysm. J Neurosurg 50: 587, 1979.

Kassel

Peerless

: Treatment of ischemic deficits from vasospasm with intravascular expansion and induced arterial hypertension. Neurosurgery 11: 337, 1982.

Pickard

Murray

: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid hemorrhage: British aneurysm nimodipine trial. Br Med J 298: 636, 1989.

10.

Robertson

Narayan

: Cerebral arteriovenous oxygen difference as an estimate of cerebral blood flow in comatose patients. J Neurosurg 70: 222–230, 1989.

11.

Rosestein

Suzuki

: Clinical use of a portable bedside cerebral blood flow machine in the management of aneurysmal subarachnoid hemorrhage. Neurosurgery 15: 519, 1984.

12.

Sacchi

Beretta

: Non invasive cerebral regional saturation monitoring: Comparison with jugular bulb saturation in patients in coma. Crit Care Med 23 suppl A76, 1995.

13.

Solomon

Post

McMurty

III : Depression of circulating blood volume in patients after subarachnoid hemorrage: Implications for the management of symptomatic vasospasm. Neurosurgery 15: 354, 1984.

14.

Steinke

Weir

BKA

: A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm. Neurosurgery 24: 179–186, 1989.

15.

Teasdale

Jennet

: Assessment of coma and impaired consciousness: A practical scale. Lancet 2: 81, 1974.

16.

Ward

Becker

: Failure of profilactic barbiturate coma in the treatment of severe head injury. J Neurosurg 69: 15, 1988.

Intensive Care Management of Patients with Subarachnoid Hemorrhage at San Raffaele Hospital,Milan

Abstract

Get full access to this article

References